Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
07/2004
07/21/2004CN1514838A 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds
07/21/2004CN1514837A 3,7-diazabicyclo [3.3.1] for mulations as anti arhythmiccompounds
07/21/2004CN1514836A New process for preparation of oxabispidines
07/21/2004CN1514835A Benzoxazepine derivatives and their use as AMPA receptor stimulators
07/21/2004CN1514828A Pyrazole derivatives for treating HIV
07/21/2004CN1158288C Process for quickly synthesizing photochromic spirooxazine by microwave
07/21/2004CN1158073C Application of protein kinase C inhibitor in preparing medicine
07/20/2004US6765009 1,4-Disubstituted benzo-fused compounds
07/20/2004US6765006 Antagonists of amino-3-hydroxy-5-methylisoxazole-4-propionic acid (ampa) ionotropic receptors; neurodegenerative, alzheimer's, and huntington's disease; amyotrophic lateral sclerosis; schizophrenia, excitatory amino acid deficiency
07/20/2004US6764996 Bactericides for infections
07/20/2004CA2286733C Reverse-turn mimetics and methods relating thereto
07/15/2004WO2004058775A1 Method for the continuous production of intermediate products in order to obtain 3-hydroxypyridine compounds
07/15/2004WO2004058774A1 Method for producing pyridoxine or an acid addition salt thereof
07/15/2004WO2004058743A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
07/15/2004WO2004058144A2 Antibacterial agents
07/15/2004WO2004041158A3 Rifalazil compositions and therapeutic regimens
07/15/2004WO2004006846A3 Receptor-type kinase modulators and methods of use
07/15/2004WO2003045312A3 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin
07/15/2004US20040138451 Epindolidione pigments
07/15/2004US20040138282 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
07/15/2004US20040138222 Post-trauma stress disorder, attention deficit disorders, obsessive compulsive disorders; anxiolytic agents; eating disorders; premenstrual disordrers
07/15/2004US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/15/2004US20040138202 Tetracyclic azepinoindole compounds
07/15/2004CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
07/14/2004EP1436294A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity
07/14/2004EP1373273A4 Process for preparing maytansinol
07/14/2004EP1210350B1 Water soluble sdz-rad esters
07/14/2004EP1196170B1 Use of a macrolide compound for the manufacture of a medicament for the treatment of brain damage caused by ischemia or hemorrhage
07/14/2004CN1512983A Compounds and compositions as cathepsins inhibitors
07/14/2004CN1157396C Process for production of levo-ofloxacin
07/13/2004US6762301 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
07/13/2004US6762299 Low solubility, good fastness, red to blue colorations; use pigmenting paints, plastics, printing inks, pigment preparations, electrophotographic toners and developers, powder coating, inkjet inks, color filters and cosmetics
07/13/2004US6762181 Broad antibacterial activity including drug resistant staphylococcus aureus (mrsa), pneumococcus (prsp) and enterococcus (vre); safely used in conjuction with nonsteroidal antiinflammatory drugs
07/13/2004US6761981 High efficiency and long service life; marcrocyclic rings comprising tertiary amines contained in a hole transport layer and/or luminescent layer of an electroluminescent device such as flat screen display
07/13/2004CA2192255C Treatment of chlamydia infectious diseases by rifamycin derivative
07/08/2004WO2004056799A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/08/2004WO2004045546A3 Water-soluble mesoporphyrin compounds and methods of preparation
07/08/2004US20040133000 Process for the preparation of oxabispidines
07/08/2004US20040132993 Antiviral and antimicrobial guanidine or biguanidine derivatives
07/08/2004US20040132799 Aminoalkoxyindoles and methods of use
07/08/2004US20040132798 containing a benzonitrile group and N-substituted with a tert-butylcarbonylmethyl- or a tert-butyloxycarbonylaminoethyl- group; particularly in a gelling polymer matrix to form modified release composition
07/08/2004US20040132781 Pyrazole compounds useful as protein kinase inhibitors
07/08/2004DE10261272A1 Verfahren zur kontinuierlichen Herstellung von Zwischenprodukten für die Herstellung von 3-Hydroxypyridin-Verbindungen Process for the continuous preparation of intermediates for the preparation of 3-hydroxypyridine compounds
07/08/2004DE10261271A1 Verfahren zur Herstellung von Pyridoxin oder seines Säureadditionssalzes Process for the preparation of pyridoxine or its acid addition salt
07/08/2004CA2789415A1 Macrolides
07/08/2004CA2508657A1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/07/2004EP0918519B1 Therapeutic treatment for vegf related occular diseases
07/07/2004CN1511157A Novel pyrrole derivatives as pharmaceutical agents
07/07/2004CN1511145A Oxazin (thi)one compounds used as fungicides
07/07/2004CN1511026A Granular preparations of gaboxadol
07/07/2004CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof
07/06/2004US6759536 Genetic engineering; polyketides
07/06/2004US6759065 Extraction method, pharmaceutical composition and a cosmetic composition
07/06/2004CA2312206C Novel bicyclic derivatives of amino-pyrazinones, process for preparing them and pharmaceutical compositions containing them
07/01/2004WO2004055025A1 Pure levofloxacin hemihydrate and processes for preparation thereof
07/01/2004WO2004026819A3 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR
07/01/2004US20040127493 Antidepressant azaheterocyclylmethyl derivatives of 4,5-dihydroimidazo[1,4,5-de ][1,4]benzoxazine
07/01/2004US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2
07/01/2004US20040127482 Substituted heterocycle fused gamma-carbolines
07/01/2004US20040123948 Adjust adhesion at interface of microelectronics packages; shrinkage inhibition
07/01/2004DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments
06/2004
06/30/2004EP1432734A1 Cytokine receptor
06/30/2004EP1432705A2 Dual action antibiotics
06/30/2004EP1432408A1 Pharmaceutical compositions comprising colloidal silicon dioxide
06/30/2004EP1282625B1 Benzoxazines for use in the treatment of parkinson's disease
06/30/2004EP1019408B1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES
06/30/2004CN1509291A Oxazolo-and-furopyrimidines and their use in medicaments against tumors
06/30/2004CN1509187A Cytotoxic CD44 antibody immunoconjugates
06/29/2004CA2263913C Substituted 6,6-hetero-bicyclic derivatives
06/24/2004WO2004052373A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
06/24/2004US20040122230 Opiate analogs selective for the delta -opioid receptor
06/24/2004US20040122063 Ethylenediamine derivatives
06/24/2004US20040122041 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
06/24/2004US20040122037 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity
06/24/2004US20040121996 Benzoxazin-3-ones and derivatives thereof as therapeutic agents
06/24/2004CA2508601A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
06/23/2004EP1429776A2 Tricyclic indole derivatives as 5-ht ligands
06/23/2004EP1429765A2 Inhibitors of histone deacetylase
06/23/2004EP1188756B1 Novel azetidine derivative and process for preparation thereof
06/23/2004CN1507449A 1-oxa-3,9-diaza-spiro [5,5] undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor
06/23/2004CN1507446A Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
06/23/2004CN1154651C Method for separating analogous organic compounds
06/22/2004CA2114113C Cardiac output probe assembly
06/17/2004WO2004050645A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
06/17/2004WO2004050085A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
06/17/2004WO2004050036A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
06/17/2004US20040116460 Anticancer agents
06/17/2004US20040116454 Pyrazole compounds useful as protein kinase inhibitors
06/17/2004US20040116445 Substituted thioacetamides
06/17/2004CA2508315A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
06/17/2004CA2498089A1 Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
06/16/2004EP1428534A1 Benzofurazan derivatives for enhancing glutamatergic synaptic responses
06/16/2004EP1427720A1 3-substituted-4-pyrimidone derivatives
06/16/2004EP1427709A1 3-substituted-4-pyrimidone derivatives
06/16/2004EP1427457A1 Medical devices containing rapamycin analogs
06/16/2004EP1064942B1 Sustained release preparation of a macrolide
06/16/2004EP0817635B1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
06/15/2004CA2086642C Method of treating hyperproliferative vascular disease
06/10/2004WO2004048339A1 Isoquinoline compounds and medicinal use thereof
06/10/2004WO2004047837A2 Beta-blockers having antioxidant and nitric oxide-donor activity